分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

3D PCL/collagen nanofibrous medical dressing for one-time treatment of diabetic foot ulcers

Ting Chang, Huiyi Yin, Xi Yu, Lihuan Wang, Longfei Fan, John H. Xin, Hui Yu

Journal:COLLOIDS AND SURFACES B-BIOINTERFACES

IF:6

DOI:10.1016/j.colsurfb.2022.112480

PMID:35358884

Published:2022-03-26

research field:肿瘤学分子生物学中医药药理学

Abstract

Nanofibrous dressings exhibit high specific surface areas, good histocompatibility , enhanced wound healing, and reduced inflammation, which have broad technological implications for treating diabetic foot ulcers (DFUs). However, current nanofibrous dressings still suffer from high resistance to cell infiltration and multiple dressing changes. In this study, polycaprolactone (PCL) and collagen were adopted as electrospinning materials to prepare a 3D PCL/Collagen (PC) nanofibrous dressing (3D-PC) using aqueous phase fibre reassembly technology. The matrix metalloproteinases (MMPs) inhibitor doxycycline hyclate (DCH)-loaded halloysite nanotubes (HNTs) ( [email protected] ) and antibacterial agent cephalexin (CEX) were loaded onto the dressing to prepare a multifunctional 3D drug-loaded PCL/Collagen nanofibrous dressing to promote DFU wound healing. The obtained 3D nanofibrous dressing exhibited high water absorption capacity and swelling capacity. It showed good antibacterial activity against Escherichia coli ( E. coli ) and Staphylococcus aureus ( S. aureus ) in vitro antibacterial test. In addition, the 3D nanofibrous dressing demonstrated good biocompatibility. It could significantly reduce the frequency of dressing changes and improve the healing of DFU wounds compared with the conventional multiple dressing changes method, suggesting a potential candidate for healing diabetic wounds.

本文使用的Yeasen产品

购物车
客服
转染试用